| |
|
|
|
Oramed Pharma
|
|
10.86 +0.18 (+1.69%) |
10/17/2017 3:59pm |
|
Open: |
10.65 |
Pre close: |
10.68 |
Target:
|
13.25
|
|
High: |
10.94 |
Low: |
10.60 |
Resistance:
|
11.34
13.25
|
|
Volume: |
20,682 |
Market Cap: |
144.66M |
Support:
|
9.68
8.65
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.88
 |
MACD |
MACD(12,26):
|
0.45  |
|
MA(20): |
10.51 |
Signal(12,26,9): |
0.49 |
|
MA(100): |
8.66 |
Stochastic Oscillator |
%K(14,3):
|
63.89 |
|
MA(250): |
7.40 |
%D(3): |
68.91 |
|
Average Volume(K) |
3-Month: |
6629
|
52-Week |
High:
|
11.34 |
|
10-Days: |
5000 |
Low: |
5.70 |
|
RSI |
RSI(14):
|
61.15 |
Change(%): |
58.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.948 |
Return on Equity (ttm) |
-49.4 |
Shares Out. (M) |
13.00 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-18.8 |
Shares Float (M) |
9.70 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.76 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
278.5 |
% Held by Institutions |
10.29 |
|
Forward EPS |
-1.270 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
185 |
|
Book Value (p.s.) |
1.487 |
EBITDA (p.s.) |
-0.881 |
P/E |
-11.46 |
|
Sales Per Share |
0.168 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
3.02 |
P/S |
64.47 |
|
Operating Margin |
-522.91 |
Levered Free Cash Flow
(M) |
-2.45 |
P/CF |
46.75 |
|
|
|
|
|
|
|
